Home

in silico Clinical Trials

“The use of individualised computer simulation in the development or regulatory evaluation of a medicinal product or medical device/medical intervention.

Event 1 Rome
The Avicenna project’s 1st Event took place in Rome, Italy on the 21st March 2014.
Event 2 - Rome
The Avicenna Project’s 2nd Meeting was held in Rome, on Friday 6th June 2014
Event 3 - Lyon
The Third Experts Meeting of the Avicenna project, took place in Lyon, France on Friday 31st of October 2014
Event 4 - Brussels
The Avicenna project’s fourth Event took place in Brussels, Belgium on 19th and 20th February 2015
Event 5 - Barcelona
Event 5 was held in Barcelona on 4th and 5th June 2015

 

Welcome to the Avicenna website!

We are a consortium funded by the European Commission, tasked with three objectives:

1. Creating a roadmap addressing the steps needed for the introduction of in silico clinical trials.

2. Establishing a partnership between the biomedical industry and European research organisations, with the aim of developing the technology, methods, protocols and standards required for in silico clinical trials to become a reality.

3. Identifying technologies, determining early examples of in silico clinical trails.

 

How can you get involved?

Over the length of the project until mid-2015 we are inviting experts and stakeholders from various relevant domains to help us by participating in discussions at a series of events. Avicenna’s ambition is to bring together representatives from the biomedical industries and regulatory agencies, researchers, and developers of computational technologies, in order to develop a pre-competitive reflection of what in silico methods can offer, and where there are scientific, technological, or regulatory barriers that, if overcome would make the development of innovative biomedical products easier, faster and cheaper.

Experts can contribute to the discussion directly on the Linkedin forum.

 

 

European Commission Funded Avicenna in silico clinical trialsAvicenna – A Strategy for in silico Clinical Trials is a Coordination and Support Action funded by the European Commission as part of the Seventh Framework Program for Research and Technological Development (FP7), under the Information Communication Technologies Programme (Contract Number 611819).